183 related articles for article (PubMed ID: 31598113)
1. T2
Matsuo-Tezuka Y; Sasaki Y; Iwai T; Kurasawa M; Yorozu K; Tashiro Y; Hirata M
Contrast Media Mol Imaging; 2019; 2019():7463047. PubMed ID: 31598113
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Tissue Elastography With Magnetic Resonance Imaging T2* and Serum Ferritin Quantification in Detecting Liver Iron Overload in Patients With Thalassemia Major.
Pipaliya N; Solanke D; Parikh P; Ingle M; Sharma R; Sharma S; Sawant P
Clin Gastroenterol Hepatol; 2017 Feb; 15(2):292-298.e1. PubMed ID: 27650324
[TBL] [Abstract][Full Text] [Related]
3. T2-star (T2*) magnetic resonance imaging for assessment of kidney iron overload in thalassemic patients.
Hashemieh M; Azarkeivan A; Akhlaghpoor S; Shirkavand A; Sheibani K
Arch Iran Med; 2012 Feb; 15(2):91-4. PubMed ID: 22292579
[TBL] [Abstract][Full Text] [Related]
4. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
[TBL] [Abstract][Full Text] [Related]
5. Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease.
Marmur J; Beshara S; Eggertsen G; Onelöv L; Albiin N; Danielsson O; Hultcrantz R; Stål P
BMC Gastroenterol; 2018 Jun; 18(1):78. PubMed ID: 29871592
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive methods for iron overload evaluation in dysmetabolic patients.
Branisso PPF; de Oliveira CPMS; Filho HML; Lima FR; Santos AS; Mancini MC; de Melo ME; Carrilho FJ; Rocha MS; Clark P; Branisso HJP; Cercato C
Ann Hepatol; 2022; 27(4):100707. PubMed ID: 35477031
[TBL] [Abstract][Full Text] [Related]
7. The Feasibility of Magnetic Resonance Imaging for Quantification of Liver, Pancreas, Spleen, Vertebral Bone Marrow, and Renal Cortex R2* and Proton Density Fat Fraction in Transfusion-Related Iron Overload.
İdilman İS; Gümrük F; Haliloğlu M; Karçaaltıncaba M
Turk J Haematol; 2016 Mar; 33(1):21-7. PubMed ID: 26376710
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal changes in LIC and other parameters in patients receiving different chelation regimens: Data from LICNET.
Vitrano A; Sacco M; Rosso R; Quota A; Fiorino D; Oliva E; Gerardi C; Roccamo G; Spadola V; Filosa A; Tesé L; Calvaruso G; Pitrolo L; Mistretta L; Cassarà F; Di Maggio R; Maggio A
Eur J Haematol; 2018 Feb; 100(2):124-130. PubMed ID: 29094403
[TBL] [Abstract][Full Text] [Related]
9. [Value of magnetic resonance imaging T2* tests in detecting heart and liver iron overload in patients with β-thalassemia major].
Wu X; Jing Y; Pei F; Chen J; Feng X; He Y; Zhang Y; Li C
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):249-52. PubMed ID: 23443782
[TBL] [Abstract][Full Text] [Related]
10. Study of the protective effects of Katha (Heartwood Extract of Acacia catechu) in liver damage induced by iron overload.
Hazra B; Sarkar R; Ghate NB; Chaudhuri D; Mandal N
J Environ Pathol Toxicol Oncol; 2013; 32(3):229-40. PubMed ID: 24266409
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility based multiparametric quantification of liver disease: Non-invasive evaluation of steatosis and iron overload.
Uhrig M; Mueller J; Longerich T; Straub BK; Buschle LR; Schlemmer HP; Mueller S; Ziener CH
Magn Reson Imaging; 2019 Nov; 63():114-122. PubMed ID: 31425813
[TBL] [Abstract][Full Text] [Related]
12. Assessment of MR-based R2* and quantitative susceptibility mapping for the quantification of liver iron concentration in a mouse model at 7T.
Simchick G; Liu Z; Nagy T; Xiong M; Zhao Q
Magn Reson Med; 2018 Nov; 80(5):2081-2093. PubMed ID: 29575047
[TBL] [Abstract][Full Text] [Related]
13. Iron overload in hemodialysis patients: Comparison of serum iron parameters with T2* MRI sequence.
Delibaş D; Evrimler Ş; Ercan K; Gümüş M; Sarıyıldırım A; Arslan H
J Clin Ultrasound; 2024 Feb; 52(2):124-130. PubMed ID: 37933208
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Iron Overload Between Age Groups Using Magnetic Resonance Imaging and Its Correlation with Iron Profile in Transfusion-dependent Thalassemia.
Wahidiyat PA; Iskandar SD; Sekarsari D
Acta Med Indones; 2018 Jul; 50(3):230-236. PubMed ID: 30333273
[TBL] [Abstract][Full Text] [Related]
15. Iron Accumulates in Retinal Vascular Endothelial Cells But Has Minimal Retinal Penetration After IP Iron Dextran Injection in Mice.
Shu W; Baumann BH; Song Y; Liu Y; Wu X; Dunaief JL
Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4378-4387. PubMed ID: 31634395
[TBL] [Abstract][Full Text] [Related]
16. MRI imaging and histopathological study of brain iron overload of β-thalassemic mice.
Yatmark P; Huaijantug S; Teerapan W; Svasti S; Fucharoen S; Morales NP
Magn Reson Imaging; 2019 Sep; 61():267-272. PubMed ID: 31128226
[TBL] [Abstract][Full Text] [Related]
17. Renal iron deposition by magnetic resonance imaging in pediatric β-thalassemia major patients: Relation to renal biomarkers, total body iron and chelation therapy.
ElAlfy MS; Khalil Elsherif NH; Ebeid FSE; Ismail EAR; Ahmed KA; Darwish YW; Ibrahim AS; Elghamry IRF; Shokrey NA; Alajeil DN
Eur J Radiol; 2018 Jun; 103():65-70. PubMed ID: 29803388
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the relationship between splenic iron overload and liver, heart and muscle features evident on T2*-weighted magnetic resonance imaging.
Çetinçakmak MG; Hattapoğlu S; Söker M; Ekici F; Yilmaz K; Göya C; Hamidi C
Adv Clin Exp Med; 2020 Apr; 29(4):475-480. PubMed ID: 32369274
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive MRI biomarkers for the early assessment of iron overload in a humanized mouse model of β-thalassemia.
Jackson LH; Vlachodimitropoulou E; Shangaris P; Roberts TA; Ryan TM; Campbell-Washburn AE; David AL; Porter JB; Lythgoe MF; Stuckey DJ
Sci Rep; 2017 Feb; 7():43439. PubMed ID: 28240317
[TBL] [Abstract][Full Text] [Related]
20. T2* MRI in regularly transfused children with thalassemia intermedia: serum ferritin does not reflect liver iron stores.
Tony S; Daar S; Elshinawy M; Al-Zadjaly S; Al-Khabori M; Wali Y
Pediatr Hematol Oncol; 2012 Sep; 29(6):579-84. PubMed ID: 22839111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
